Navigation Links
BioNanomatrix to Introduce nanoAnalyzer® 1000 System
Date:10/27/2010

PHILADELPHIA, Oct. 27 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, will introduce next month the nanoAnalyzer 1000 System at the American Society of Human Genetics (ASHG) Annual Meeting from November 2-6, 2010 in Washington, D.C.

The nanoAnalyzer 1000 System is intended for advanced analyses of DNA and other macromolecules and consists of a disposable nanochannel silicon-based device, analytical instrumentation, software and reagents.  The system is currently being tested in collaboration with leading researchers in the genomics field.

"This event is the culmination of several years of effort to develop a complete system for state-of-the-art analyses of DNA and potentially other large molecules of biological interest," said Edward L. Erickson, BioNanomatrix's president and chief executive officer.  "We expect to make the nanoAnalyzer 1000 System available to early access customers following the New Year."

The company further announced that it is developing a wide range of applications for the nanoAnalyzer 1000 System, including:

  • Assessment of DNA sample quality for advanced sequencing and other genomic analysis methods;
  • Assessment of DNA damage induced by environmental factors such as ionizing radiation and pollutants;
  • Adjunctive methods for assisting researchers in genome assembly, assembly validation, finishing and scaffolding; and
  • Identification and analysis of structural variations in genomic DNA.

  • The nanoAnalyzer 1000 System on display at Booth #723 at ASHG, which is being held at the Walter E. Washington Convention Center in Washington, D.C.  Inquiries concerning the company and its products should be addressed to info@bionanomatrix.com.

    About BioNanomatrix

    BioNanomatrix, Inc., a privately held ge
    '/>"/>

    SOURCE BioNanomatrix, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related biology news :

    1. Motorola Solutions Introduces Industrys Most Comprehensive Enterprise Device Management Platform
    2. Elsevier introduces Protein Viewer, bringing science to life
    3. Aware to Introduce Several New Software Products at the Biometrics Consortium Conference
    4. InQ Biosciences Introduces First Fully Integrated Cell Research System
    5. Orbel Introduces the Board Shielding Wizard
    6. Cermetek Introduces Medically Approved Modem Module
    7. Olympus introduces the VisiGlide, a single-use guidewire
    8. Advanced Analogic Technologies Introduces Lowest-Power Load Switch Available for Biometric Security Devices
    9. Reintroduced Chinese alligators now multiplying in the wild in China
    10. New blackberry introduced
    11. e-Smart Technologies to Introduce Next Generation I AM Smart Card Technology at Cartes 2008 in Paris
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
    (Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of the ... their offering. One major trend emerging ... advances in technology, it is important to upgrade biometric ...
    (Date:12/11/2014)... 2014  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ...
    Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
    ... a big decision. And, at least for mice, it's one that ... series of experiments designed help scientists understand the brain chemicals that ... odors of either a male mouse alone or a male mouse ... linked to other females. , "Our data suggest that female mice ...
    ... of Allergy and Infectious Diseases (NIAID), part of ... that enrollment into a large international HIV/AIDS trial ... guided by levels of CD4+ cells has been ... episodic therapy had twice the risk of disease ...
    ... of Texas M. D. Anderson Cancer Center have created ... ability to find, highlight, and deliver genes to tumors ... the journal Cell, is potentially an important step in ... treatment; it may also allow prediction and monitoring of ...
    Cached Biology News:When mice choose mates, experience counts 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 2International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 3International HIV/AIDS trial finds continuous antiretroviral therapy superior to episodic therapy 4New hybrid virus provides targeted molecular imaging of cancer 2
    (Date:1/22/2015)... Protocol Networks brings independent technology consulting to the ... consultants, Protocol Networks has recently announced its expansion into ... his company has attracted several clients in The Constitution ... as others. With the success of these engagements, Rogers ...
    (Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited ... seminar on probiotics in San Diego, CA. , The ... for health care professionals. This year’s pre-conference seminar was held ... health. Dr. Leyer spoke about the emerging topics and science ...
    (Date:1/22/2015)... BRUNSWICK , Nueva Jersey , 22 de ... Award for Biomedical Research abre hoy su llamada a ... personas cuya investigación científica ha hecho, o tiene el ... la salud humana. Las nominaciones se aceptarán hasta el ...
    (Date:1/22/2015)... PRINCETON, N.J. , Jan. 22, 2015  Derma ... tissue regeneration company focused on advanced wound care, ... from placental tissues, have been added to the ... announcement increases the opportunity for the AMNIOEXCEL® and ...
    Breaking Biology Technology:Protocol Networks Brings Independent Technology Consulting to the Constitution State 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5
    ... Cardium Therapeutics (NYSE Amex: CXM ) today announced ... U.S. Food and Drug Administration (FDA) seeking marketing clearance ... XL is an advanced wound care management medical ... for use by physicians in patients with topical wounds, ...
    ... , BENLYSTA(TM) Successful in Second Pivotal Clinical Trial ... (HGS) and GlaxoSmithKline (GSK) today announced positive results from ... trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. ... shared at the 73rd Annual Scientific meeting of the ...
    ... , KENILWORTH, N.J., Oct. 30 /PRNewswire-FirstCall/ ... ) announced today the U.S. Food and Drug ... to the company,s supplemental Biologics License Application regarding ... of patients with stage III malignant melanoma after ...
    Cached Biology Technology:Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 2Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 3Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds 4Promise of a New Lupus Treatment Is a Groundbreaking Achievement 2Promise of a New Lupus Treatment Is a Groundbreaking Achievement 3U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 2U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 3U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 4U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 5U.S. Food and Drug Administration Issues Complete Response Letter Regarding PEGINTRON(R) for Malignant Melanoma 6
    ...
    ...
    ... Specificity: This antibody recognizes murine ... cross-react with other related IRF ... with murine IRF7 protein was ... of the 293T cells transfected ...
    ...
    Biology Products: